# Distinguishing Participant Groups Using Autonomic Dysfunction

> **NCT05199350** · — · COMPLETED · sponsor: **DyAnsys, Inc.** · enrollment: 175 (actual)

## Conditions studied

- Diabetes

## Interventions

- **OTHER:** Device Name: ANSiscope

## Key facts

- **NCT ID:** NCT05199350
- **Lead sponsor:** DyAnsys, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-17
- **Primary completion:** 2022-07-29
- **Final completion:** 2022-07-29
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05199350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05199350, "Distinguishing Participant Groups Using Autonomic Dysfunction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05199350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*